143 results
424B4
RVPH
Reviva Pharmaceuticals Holdings Inc.
13 Feb 24
Prospectus supplement with pricing info
5:00pm
an election of a director or directors) shall be decided by a majority of the votes properly cast on such matter, except where a different vote … , or matters relating solely to the terms of preferred stock, in which case, such different vote shall apply. A majority in voting power of the shares
8-K
EX-4.1
ihh2o5eochchm2hs
17 Nov 23
Reviva Announces $30 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:05pm
8-K
EX-4.2
dor6 z3uj
17 Nov 23
Reviva Announces $30 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:05pm
8-K
EX-10.1
joy3w tjb
17 Nov 23
Reviva Announces $30 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:05pm
424B5
pzzk9gzkxu9lno x2
17 Nov 23
Prospectus supplement for primary offering
4:03pm
424B3
l86v5a9
5 Apr 23
Prospectus supplement
5:10pm
POS AM
hk5z5gkgv4m2r8rho0h3
30 Mar 23
Prospectus update (post-effective amendment)
8:06am
8-K
EX-99.1
ouw2i4 fdb
30 Mar 23
Reviva Pharmaceuticals Holdings, Inc. Reports Full Year 2022 Financial Results and Recent Business Highlights
7:46am
424B4
foay6pq w9fvt
18 Oct 22
Prospectus supplement with pricing info
7:01am